Personalized Medicine for Metabolic Diseases: Novel Tools for the Study of Pathogenic Mechanisms and Treatment
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 10 June 2024 | Viewed by 271
Special Issue Editor
Interests: protein biophysics; protein–ligand interactions; protein structure and dynamics; protein stability; protein degradation; enzymology; conformational diseases; pharmacological therapies; genotype–phenotype correlations; pathogenic mechanisms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In 2021, we presented a Special Issue entitled “Genotype–Phenotype Relationships, Molecular Mechanisms and Personalized Therapy of Metabolic Diseases”, which highlighted excellent contributions from researchers across the world. On behalf of myself and JPM, as an invited editor, I am pleased to present a second issue on this topic.
Background and history of this topic: Metabolic diseases are often genetic and rare, affecting less than 1/10000 individuals. However, as there are thousands of these diseases, many millions of individuals are affected. The human and social burdens are clear, and new therapeutic approaches and needed.
Aim and scope of this Special Issue: From a biochemical, biophysical and cell biology point of view, the treatment of inherited metabolic diseases is challenging. We welcome multidisciplinary original research and review articles that address the molecular mechanisms of these diseases, as well as novel approaches to their investigation and treatment.
Cutting-edge research: We aim to gather papers that use classical and state-of-the-art tools to unravel different aspects of metabolic diseases (such as structure–function relationships), and welcome metabolomic and proteomic studies. We also aim to present current advances in X-ray crystallography and cryo-EM for the investigation of these diseases.
What kinds of papers we are soliciting: We seek reviews, comments and original research. It is particularly important that manuscripts be of high quality and relevance if state-of-the-art approaches are used, described or discussed.
Dr. Angel L. Pey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inherited metabolic disease
- cancer
- molecular mechanisms
- novel therapies
- genomics and proteomics
- structural biology
